Reduction in total cardiovascular events with the pcsk9 inhibitor evolocumab in patients with cardiovascular disease in the combined fourier and fourier open-label extension (ole) studies
Journal of the American College of Cardiology（2023）
关键词
pcsk9 inhibitor evolocumab,total cardiovascular events,cardiovascular disease,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要